Companies /Basic Materials

DuPont de Nemours Inc

NYSE: DD Specialty Chemicals
$127.98
▼ $3.34 (−2.54%) today
Markets open · 4:10pm ET

Q2 2025 Earnings

Reported Aug 5, 2025, 6:06am ET · SEC source
$1.12
Beat +5.52%
EPS · est. $1.06
$3.3B
Beat +0.46%
Revenue · est. $3.2B
+4.1%
Beating market
DD vs S&P since report
5 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−3%0Aug 5Aug 6report 6:06am ETearnings+0.1%−4.7%
−3%0Aug 5Aug 6earnings+0.1%−4.7%
DD −4.7%S&P 500 +0.1%
−3%0Aug 5Aug 6report 6:06am ETearnings+0.1%−4.7%
−3%0Aug 5Aug 6earnings+0.1%−4.7%
DD −4.7%NASDAQ +0.1%
−6%−3%0Aug 4Aug 13report 6:06am ETearnings+1.8%−4.0%
−6%−3%0Aug 4Aug 13earnings+1.8%−4.0%
DD −4.0%S&P 500 +1.8%
−6%−3%0+3%Aug 4Aug 13report 6:06am ETearnings+2.7%−4.0%
−6%−3%0+3%Aug 4Aug 13earnings+2.7%−4.0%
DD −4.0%NASDAQ +2.7%
+2.38%
Day of report
−2.48%
Next session
−0.92%
One week
+7.19%
30 days

S&P 500 over the same 30 days: +3.07%.

Did DD Beat Earnings? Q2 2025 Results

DuPont de Nemours delivered a solid second quarter, posting adjusted EPS of $1.12 against a consensus estimate of $1.06, a 5.52% beat, while revenue of $3.26 billion edged past expectations by 0.46% and grew 2.7% year-over-year. The standout driver behind the quarter was the ElectronicsCo segment, which generated $1.17 billion in net sales with 6% organic growth, fueled by surging demand for AI-related semiconductor technologies and strong interconnect content gains. Operating EBITDA reached $859 million, with margin expanding 120 basis points to 26.4%, reflecting disciplined execution even as construction market softness weighed on the IndustrialsCo segment. The broader industrial landscape has seen companies navigate meaningful tariff headwinds this cycle, and DuPont is no exception, absorbing an estimated $20 million net tariff impact for the full year, though stronger core performance more than offsets that pressure. Looking ahead, the company raised full-year guidance to approximately $4.40 in adjusted EPS and $12.85 billion in net sales, while targeting a November 1 spin-off of its electronics business, Qnity.

Key Takeaways
  • Continued strength in electronics, healthcare and water end-markets
  • Volume growth of 4% driven by advanced node and AI technology applications
  • Operational execution and productivity improvements
  • ElectronicsCo organic sales growth of 6% with 220 bps margin expansion
  • AI-driven technology ramps and content/share gains in Interconnect Solutions
  • Lower tax rate contributing to adjusted EPS growth

“We delivered another quarter of year-over-year organic sales growth and solid margin expansion in both the ElectronicsCo and IndustrialsCo segments, as well as 15 percent adjusted EPS growth. Ongoing strength in electronics, healthcare and water end-markets, along with our team's focus on operational execution continued to drive strong earnings growth and cash conversion. As a result of our strong second quarter performance, we are raising our full year earnings guidance, which now incorporates the impact of tariffs.”

DuPont de Nemours CEO, on the earnings call

Forward Guidance & Outlook

DuPont raised full-year 2025 guidance: net sales of approximately $12.85 billion, operating EBITDA of approximately $3.36 billion, and adjusted EPS of approximately $4.40, now incorporating an estimated $20 million net tariff headwind ($0.04 per share). For Q3 2025, the company guides net sales of approximately $3.32 billion, operating EBITDA of approximately $875 million, and adjusted EPS of approximately $1.15, assuming about 3% organic growth year-over-year with continued strength in healthcare, water, and electronics end-markets, partially muted by continued weakness in construction end-markets.

DD YoY Financials

Q2 2025 vs Q2 2024 · SEC filings Q2 2024 Q2 2025
$0$900.0M$1.8B$2.7B$3.2B$3.3BRevenue$1.0B$1.2BGross Profit$472.0M$306.0MOperating Income$178.0M$238.0MNet Income
$0$900.0M$1.8B$2.7BRevenueGross ProfitOperating IncomeNet Income

DD Revenue by Segment

Industrials$2.1B+1.0%
Electronics$1.2B+6.0%
Diversified Industrials
Healthcare and Water Technologies

DD Revenue by Geography

Asia Pacific$1.4B+4.0%
United States$1.2B+2.0%
EMEA$576.0M+5.0%
Latin America$114.0M−7.0%

Figures from SEC filings and company reports. Not investment advice.